期刊文献+

乌司他丁在体外循环心脏手术中对心肌的保护作用 被引量:4

Effects of ulinastatin on myocardial protection in patients undergoing cardiac operation with cardiopulmonary bypass
暂未订购
导出
摘要 目的 探讨心脏手术体外循环 (CPB)中促炎细胞因子、心功酶、肌钙蛋白 (cTnI)的变化及应用乌司他丁(UTI)对心肌的保护作用。方法  60例风湿性心脏病行瓣膜置换术的患者分为两组 ,UTI组 (U组 ) 3 2例 ,对照组 (C组 ) 2 8例。U组接受UTI 90万IU ,于麻醉后至CPB前缓慢静注 3 0万IU ,另 60万IU一次性加入预充液中 ;C组不接受UTI。分别于术前、术毕、术后第 1,3 ,7天测量血浆白细胞介素 (IL) -6、IL -8及肿瘤坏死因子 -α(TNF -α) ,乳酸脱氢酶 (LDH)、磷酸肌酸激酶同工酶 (CK -MB)、cTnI水平 ;记录心脏复跳及术后正性肌力药物的应用情况。结果 ①炎性细胞因子术前各指标均无差异 ,术后显著升高 (P <0 0 5 ) ;IL -6,IL -8,TNF -α以术毕最高 ,此后逐渐下降 ;组间比较 ,术毕、术后第 1天U组IL -6,IL -8,TNF -α水平较C组低 (P <0 0 5 )。②CK -MB及cTnI术毕最高 ,LDH术后第 1天最高 ,此后逐渐下降 ;组间比较 ,术毕 3项指标U组均低于C组 (P <0 0 1~ 0 0 5 )。③术毕IL -6与LDH及cTnI,IL -8与CK -MB及LDH均成显著正相关 (P <0 0 0~ 0 0 5 )。④升主动脉开放后心脏自动复跳率U组为 81% ,C组为 79%。术后U组应用多巴胺的平均最大剂量少于C组 (P <0 0 5 ) ,U组肾上腺素的平均使用时间少于C组 (P <0 0 Objective To investigate the perioperative alteration of proinflammatory cytokines, myocardial enzymes and cardiac troponin I(cTnI) under cardiopulmonary bypass and the effects of ulinastatin(UTI) on myocardial protection. Methods Sixty patients with rheumatic heart disease undergoing cardiac valve replacement were divided into two groups: UTI group(group U, n =32) received 30 000 IU UTI intravenously before cardiopulmonary bypass(CPB) and 60 000 IU in the priming solution; Control group (group C, n =28) did not receive UTI intravenously or in the priming. Blood samples were taken before skin incision(T1), at the end of operation(T2), and on the first(T3),the third(T4) and the seventh(T5) postoperative day for determination of plasma IL-6, IL-8, TNF-α, CK-MB, LDH and cTnI. Results ①IL-6,IL-8,TNF-α level at T2 and T3 in group U were lower than those in group C( P <0 05). ②CK-MB, LDH, cTnI level at T2 in group U were lower than those in group C( P <0 05). ③Correlation analysis shows IL-6 level at T2 correlated with LDH and cTnI. IL-8 level at T2 correlated with CK-MB and LDH( P =0 00~0 05). ④After cross-clamping releasing, the spontaneous return rate is 81% in group U and 79% in group C. The amount of inotropic drugs used postoperatively in group U is less than that in group C( P <0 05). Conclusion UTI is effective in reducing inflammatory response induced by CPB and can decrease myocardial injury.
出处 《广东医学》 CAS CSCD 2003年第5期481-483,共3页 Guangdong Medical Journal
基金 广州市科委科研资助项目 (编号 :JB0 2 - 2 0 0 0 -X - 0 0 5- 0 1 - 0 3)
关键词 乌司他丁 体外循环 心脏手术 心肌 保护作用 Cardiopulmonary bypass Ulinastatin Myocardial protection Inflammation mediator
  • 相关文献

参考文献5

  • 1吉冰洋.体外循环中乌司他丁对机体的保护作用[J].中国胸心血管外科临床杂志,2002,9(1):51-53. 被引量:36
  • 2于金贵,周广利,孟冬梅,帅训军,类维富,应诗达.乌司他丁对心脏直视手术患者围体外循环期炎性细胞因子和自由基的影响[J].中华麻醉学杂志,2001,21(12):724-726. 被引量:55
  • 3Hall RI, Smith MS, Rocker G. The systemic inflammatary response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg, 1997,85:766.
  • 4Khabar KS, elBarbary MA, Khouqeer F, et al. Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duralion of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immund Immunopathol,1997, 85:97.
  • 5Haring F, Feyrer R, Mahmoud FO, et al. Reducing the post- pump syndrome by using heparin - coated circuits, steroids or apratinin. Thorac Cardiovasc Surg. 1999. 47:111.

二级参考文献24

  • 1[1]Sato Y,Ishikawa S,Otaki A,et al.Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin.Inhibiting cytokines and postoperative organ injury.Jpn J Thorac Cardiovasc Surg,2000,48(7):428-434.
  • 2[2]Conlon PJ,Stafford-Smith M,White WD,et al.Acute renal failure following cardiac surgery.Nephrol Dial Transplant,1999,14(5):1158-1162.
  • 3[3]Suen WS,Mok CK,Chiu SW,et al.Risk factors for development of acute renal failure(ARF) requiring dialysis in patients undergoing cardiac surgery.Angiology,1998,49(10):789-800.
  • 4[4]Oshima N,Yamada T,Nakahara H,et al.Effect of ulinastatin(UL) on renal function and lactic acidosis during open-heart surgery:comparison with aprotinin.Kyobu Geka,1990,43(5):357-363.
  • 5[5]Ueki M,Yokono S,Nogaya J,et al.Effects of ulinastatin on postoperative renal function after cardiopulmonary bypass.Masui,1995,44(5):691-697.
  • 6[6]Yonoko S,Ueki M,Nakayo M,et al.Urinary excretion of ulinastatin and NAG after cardiopulmonary bypass.Masui,1997,46(3):388-392.
  • 7[7]Ueki M,Yokono S,Komatsu H,et al.The support of postoperative renal function by ulinastatin inpatients with preoperative renal dysfunction.Masui,1995,44(4):570-573.
  • 8[8]Nakakuki M,Yamasaki F,Shinkawa T,et al.Protective effect of human ulinastatin against gentamicin-induced acute renal failure in rats.Can J Physiol Pharmacol,1996,74(1):104-111.
  • 9[9]Ueki M,Yokono S,Taie S,et al.Supplement of ulinastatin on renal function after cardiopulmonary bypass.Masui,2000,49(2):163-167.
  • 10[10]Tanita T,Song C,Kubo H,et al.Superoxide anion mediates pulmonary vascular permeability caused by neutrophils in cardiopulmonary bypass.Surg Today,1999,29(8):755-761.

共引文献86

同被引文献13

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部